Abstract: A separation channel on which a liquid delivery pump, a separation column, and a detector are provided, the liquid delivering pump being for feeding a mobile phase, the separation column being for separating a component in a sample, and the detector being for detecting peaks of components separated from each other by the separation column, a plurality of liquid handlers each including an injecting part and a collecting part, wherein when one of the plurality of liquid handlers is introduced into the separation channel, the injecting part of the one of the plurality of liquid handlers functions as an injector that executes injection operation of a sample into a mobile phase flowing through the analysis channel upstream of the separation column in the analysis channel and the collecting part of the one the plurality of liquid handlers functions as a fraction collector that executes collection operation of peaks of components separated from each other in the separation column, a selector for selectively switchin

Abstract: A preparative liquid chromatograph including an analysis channel (2), an injector (6), a separation column (8), a detector (10), a plurality of fraction collectors (14-1 to 14-n), a switching valve (12) that switches fraction collectors (14-1 to 14-n) to be connected to the outlet of the detector (10) among the plurality of fraction collectors (14-1 to 14-n), and a controller (16) for controlling operations of the plurality of fraction collectors (14-1 to 14-n) and the switching valve (12). In a case where the number of remaining unused collection containers of the fraction collector in use, which is connected to the outlet of the detector, falls below the number of buffers which is an integer of two or more, the controller (16) is configured to switch the switching valve (12) while the fraction collector in use is not performing a peak collection operation.

Abstract: A hollow article is molded in a state where an inner surface of a neck portion including an inner screw portion is held by an inner neck mold, and then, the hollow article is demolded from the inner neck mold by inserting an ejection rod into the hollow article to be engaged with an inner surface of the hollow article and rotating the hollow article together with the ejection rod.

Abstract: A composition for a secondary battery negative electrode including a carbonaceous material (a) and a silicon oxide structure (b), wherein the silicon oxide structure (b) includes a silicon oxide framework containing Si and O in its atomic composition and silicon-based nanoparticles that are chemically bonded to the silicon oxide framework as components, wherein the silicon oxide structure (b) is contained in a proportion of 15 mass % or more with respect to a total amount of the carbonaceous material (a) and the silicon oxide structure (b), and wherein the silicon oxide structure (b) satisfies the following conditions (i) to (iii): (i) having an atomic composition represented by a general formula SiOx2Hy2 (0.3<x2<1.5, 0.01<y2<0.35), (ii) having Si—H bonds, and (iii) being essentially free of carbon.

Abstract: There are provided a material for a negative electrode active material exhibiting a favorable capacity retention rate and Coulomb efficiency, a method of producing the material, a negative electrode composition using the material, a negative electrode, and a secondary battery. A SiOC structure, includes (A) at least one silicon-based fine particles; and (B) a SiOC coating layer containing at least Si (silicon), O (oxygen), and C (carbon) as constituent elements, wherein the at least one silicon-based fine particles are covered with the SiOC coating layer, and the average particle size based on a volume-based particle size distribution is in a range of 1 nm to 999 ?m.

Abstract: A hollow article 10 is molded in a state where an inner surface of a neck portion 11 including an inner screw portion is held by an inner neck mold 52, and then, the hollow article 10 is demolded from the inner neck mold 52 by inserting an ejection rod 81 into the hollow article 10 to be engaged with an inner surface of the hollow article 10 and rotating the hollow article 10 together with the ejection rod 81.

Abstract: A composition for a secondary battery negative electrode including a carbonaceous material (a) and a silicon oxide structure (b), wherein the silicon oxide structure (b) includes a silicon oxide framework containing Si and O in its atomic composition and silicon-based nanoparticles that are chemically bonded to the silicon oxide framework as components, wherein the silicon oxide structure (b) is contained in a proportion of 15 mass % or more with respect to a total amount of the carbonaceous material (a) and the silicon oxide structure (b), and wherein the silicon oxide structure (b) satisfies the following conditions (i) to (iii): (i) having an atomic composition represented by a general formula SiOx2Hy2 (0.3<x2<1.5, 0.01<y2<0.35), (ii) having Si—H bonds, and (iii) being essentially free of carbon.

Abstract: Performance improvement and cost reduction in a positive electrode active material for a lithium ion battery. A method of manufacturing a lithium nickel composite oxide including the following Steps 1 to 7: (Step 1) a dissolving step; (Step 2) a precipitation step; (Step 3) a filtering step; (Step 4) a drying step; (Step 5) a mixing step of mixing aluminum hydroxide and lithium carbonate with the precursor powder, which is obtained in Step 4, to obtain a mixture; (Step 6) a high-temperature firing step of firing the mixture, which is obtained in Step 5, at a high temperature of higher than 790° C. to obtain a fired product; and (Step 7) a low-temperature firing step of firing the fired product, which has undergone Step 6, at a low temperature of lower than 790° C.

Abstract: An oxygen-containing heterocyclic compound represented by following Formula (I): wherein R1 and R2 independently represent hydrogen, lower alkyl, cyano, —(CH2)n—E1—CO—G1 (wherein E1 represents a bond, O, or NH; and G1 represents hydrogen, substituted or unsubstituted lower alkyl, OR6, or NR7R8; and n represents an integer of 0 to 4), or the like; R1 and R2 are combined to represent a saturated carbon ring together with a carbon atom adjacent thereto; or R2, and R11 or R13 described below are combined to form a single bond; R3 represents hydrogen, phenyl, or halogen; R4 represents hydroxy, lower alkoxy, or the like; A represents —C(R9)(R10)— or O; B represents O, NR11, —C(R12)(R13)—, or —C(R14)(R15)— C(R16)(R17)—; D represents (i) —C(R18)(R19)—X— (wherein X represents —C(R21)(R22)—, S, or NR23), (ii) —C(R19a)═Y— [Y represents —C(R24)—Z— (wherein Z represents

Abstract: An oxygen-containing heterocyclic compound represented by following Formula (I): wherein R1 and R2 independently represent hydrogen, lower alkyl, cyano, —(CH2)n—E1—CO—G1 (wherein E1 represents a bond, O, or NH; and G1 represents hydrogen, substituted or unsubstituted lower alkyl, OR6, or NR7R8; and n represents an integer of 0 to 4), or the like; R1 and R2 are combined to represent a saturated carbon ring together with a carbon atom adjacent thereto; or R2, and R11 or R13 described below are combined to form a single bond; R3 represents hydrogen, phenyl, or halogen; R4 represents hydroxy, lower alkoxy, or the like; A represents —C(R9)(R10)— or O; B represents O, NR11, —C(R12)(R13)—, or —C(R14)(R15)—C(R16)(R17)—; D represents (i) —C(R18)(R19)—X— (wherein X represents —C(R21)(R22)—, S, or NR23), (ii) —C(R19a)═Y— [Y represents —C(R24)—Z— (wherein Z represents C

Abstract: An oxygen-containing heterocyclic compound represented by following Formula (I): 1

Abstract: The present invention relates to compounds represented by formula (I): ##STR1## wherein Z represents Gly or Cys; X represents an (.alpha.-amino acid residue; Y represents a natural calcitonin moiety, a partial natural calcitonin peptide moiety, or a natural calcitonin-like peptide moiety; m represents an integer of 5-8, .alpha.-amino acid residues represented by X being the same or different; and n represents an integer of 0-3; provided that when m is 5, the sequence of 4 C-terminal residues of --(X).sub.m -- is different from the sequence of the third to sixth amino acids of natural calcitonin, and pharmaceutically acceptable salts thereof.

Abstract: The present invention relates to propenone derivatives represented by the following formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, or YR.sup.5 (wherein Y represents S or O; and R.sup.5 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or a substituted or unsubstituted cyclic ether residue); R.sup.2 and R.sup.3 independently represent hydrogen, lower alkyl, or substituted or unsubstituted aralkyl, or alternatively R.sup.2 and R.sup.3 are combined to form substituted or unsubstituted methylene or ethylene; R.sup.4 represents hydrogen, hydroxy, lower alkyl, substituted or unsubstituted aralkyl, lower alkoxy, substituted or unsubstituted aralkyloxy, or halogen; and X represents substituted or unsubstituted indolyl; or pharmaceutically acceptable salts thereof.

Abstract: The present invention relates to indole derivatives represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2 independently represent hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen, --O--(CH.sub.2).sub.n --OR.sup.5, or ##STR2## R.sup.3 represents hydrogen, lower alkyl, or ##STR3## R.sup.4 represents hydroxy, lower alkoxy, substituted or unsubstituted aryloxy, or --NR.sup.10 R.sup.11, and X represents CO or SO.sub.2, with the proviso that when R.sup.3 is hydrogen or lower alkyl, and X is CO, R.sup.4 is --NR.sup.10 R.sup.11, or pharmaceutically acceptable salts thereof.

Abstract: This invention relates to a novel tetracyclic compound represented by formula (I): ##STR1## or its pharmacologically-acceptable salt. The compound of this invention has strong immunosuppressive activity, and is useful as an immunosuppressive agent and as an agent for treating autoimmune disease.

Abstract: Pyrazolothiazolopyrimidine derivatives represented by the Formula ##STR1## and pharmaceutically acceptable salts thereof are useful as anti-inflammatory, analgesic, immunomodulatory and anti-ulcer agents.

Abstract: The present invention relates to novel tetracyclic compounds represented by formula (I) ##STR1## (wherein each of X.sup.1 and X.sup.2 independently represents hydrogen or lower alkyl; n represents an integer of 1 to 4), or a pharmaceutically acceptable salt thereof, which are useful as immunosuppressive agents.

Abstract: An azaazulene derivative having the general formula (I): ##STR1## wherein R.sup.1 is hydrogen atom or isopropyl group; the bond C N between C at the 2-position and N at the 1-position is single bond or double bond; when the bond C N is single bond, R.sup.2 is 5-tetrazolyl group, R.sup.3 is taken together with carbon atom to form carbonyl group at the 2-position, and R.sup.4 is hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a lower alkenyl group, a lower alkyl group having oxygen atom or sulfur atom in carbon chain, a lower alkyl group having a halogen atom or cyano group, a lower alkyl group having heteroaromatic ring, a diphenyl lower alkyl group, or a lower alkyl group having hydrocarbon-aromatic ring with the general formula: ##STR2## in which W is single bond or carbonyl group, oxygen atom, sulfur atom or --CH.dbd.CH--, n is an integer of 1 to 6, and R.sup.1', R.sup.2' and R.sup.

Abstract: A connecting device for a rope or bar to be connected to a threaded bolt, includes a coupling threaded at one end for threaded engagement with the threaded bolt and having a radially inwardly extending annular shoulder at its other end. A sleeve swaged onto the end of the rope or bar is disposed within the coupling and engages the shoulder thereof so as to prevent disengagement therefrom. A hard metal coil and a soft metal sleeve are interposed between the rope or bar and the first sleeve for achieving enhanced gripping of the sleeve to the rope or bar.

Abstract: An azaazulene derivative having the general formula (I): ##STR1## wherein R.sup.1 is hydrogen atom or isopropyl group; the bond C N between C at the 2-position and N at the 1-position is single bond or double bond; when the bond C N is single bond, R.sup.2 is 5-tetrazolyl group, R.sup.3 is taken together with carbon atom to form carbonyl group at the 2-position, and R.sup.4 is hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a lower alkenyl group, a lower alkyl group having oxygen atom or sulfur atom in carbon chain, a lower alkyl group having a halogen atom or cyano group, a lower alkyl group having heteroaromatic ring, a diphenyl lower alkyl group, or a lower alkyl group having hydrocarbon-aromatic ring with the general formula: ##STR2## in which W is single bond or carbonyl group, oxygen atom, sulfur atom or --CH.dbd.CH--, n is an integer of 1 to 6, and R.sup.1', R.sup.2' and R.sup.